Second Human Pegivirus in Hepatitis C Virus–Infected and Hepatitis C Virus/HIV-1–Co-infected Persons Who Inject Drugs, China
We report the presence of the second human pegivirus (HPgV-2) in Guangdong and Sichuan Provinces in China. The prevalence of HPgV-2 in hepatitis C virus/HIV-1–co-infected persons who inject drugs was 12.9% in Guangdong and 15.9% in Sichuan. This population is at high risk for HPgV-2 infection.
Main Authors: | Haiying Wang, Zhengwei Wan, Qiang Sun, Nalin Zhu, Tianyi Li, Xuqi Ren, Xiaoping An, Shuyun Deng, Yue Wu, Xiufen Li, Lin Li, Jingyun Li, Yigang Tong, Shixing Tang |
---|---|
Format: | Article |
Language: | English |
Published: |
Centers for Disease Control and Prevention
2018-05-01
|
Series: | Emerging Infectious Diseases |
Subjects: | |
Online Access: | https://wwwnc.cdc.gov/eid/article/24/5/16-1162_article |
Similar Items
-
Difference of Intrahost Dynamics of the Second Human Pegivirus and Hepatitis C Virus in HPgV-2/HCV-Coinfected Patients
by: Yuanhao Liang, et al.
Published: (2021-08-01) -
Prevalence of human pegivirus-1 and sequence variability of its E2 glycoprotein estimated from screening donors of fetal stem cell-containing material
by: Yakov Vitrenko, et al.
Published: (2017-08-01) -
Tropism of human pegivirus (formerly known as GB virus C) and host immunomodulation : insights into viral persistence
by: Chivero, Ernest Tafara
Published: (2015) -
Effect of human pegivirus route of transmission on the genetic distribution of the virus: an institution based cross-sectional study
by: Wubet Taklual, et al.
Published: (2019-04-01) -
Prevalence and Clinical Impact of Human Pegivirus-1 Infection in HIV-1-Infected Individuals in Yunnan, China
by: Zhijiang Miao, et al.
Published: (2017-02-01)